DE2832090A1 - Glucagon-fragment und seine derivate - Google Patents

Glucagon-fragment und seine derivate

Info

Publication number
DE2832090A1
DE2832090A1 DE19782832090 DE2832090A DE2832090A1 DE 2832090 A1 DE2832090 A1 DE 2832090A1 DE 19782832090 DE19782832090 DE 19782832090 DE 2832090 A DE2832090 A DE 2832090A DE 2832090 A1 DE2832090 A1 DE 2832090A1
Authority
DE
Germany
Prior art keywords
arg
asp
gln
peptide
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19782832090
Other languages
German (de)
English (en)
Other versions
DE2832090C2 (https=
Inventor
Masahiko Fujino
Akira Ohneda
Hyogo Takarazuka
Mitsuhiro Wakimasu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP8855677A external-priority patent/JPS5424868A/ja
Priority claimed from JP11424277A external-priority patent/JPS5446776A/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DE2832090A1 publication Critical patent/DE2832090A1/de
Application granted granted Critical
Publication of DE2832090C2 publication Critical patent/DE2832090C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19782832090 1977-07-22 1978-07-21 Glucagon-fragment und seine derivate Granted DE2832090A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8855677A JPS5424868A (en) 1977-07-22 1977-07-22 Novel glucagon fragment
JP11424277A JPS5446776A (en) 1977-09-21 1977-09-21 Novel peptide

Publications (2)

Publication Number Publication Date
DE2832090A1 true DE2832090A1 (de) 1979-02-08
DE2832090C2 DE2832090C2 (https=) 1989-07-20

Family

ID=26429925

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19782832090 Granted DE2832090A1 (de) 1977-07-22 1978-07-21 Glucagon-fragment und seine derivate
DE2858718A Expired DE2858718C2 (https=) 1977-07-22 1978-07-21

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE2858718A Expired DE2858718C2 (https=) 1977-07-22 1978-07-21

Country Status (4)

Country Link
US (1) US4206199A (https=)
DE (2) DE2832090A1 (https=)
FR (1) FR2398051A1 (https=)
GB (1) GB2002387B (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009147A3 (en) * 1978-08-30 1980-04-30 Takeda Chemical Industries, Ltd. A method for enzyme immunoassay of pancreatic glucagon and a peptide-enzyme conjugate usable for the method
DE3039122A1 (de) * 1979-10-16 1981-04-30 Toyo Jozo K.K., Tagata, Shizuoka Glucagonfragment und seine verwendung

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56163456A (en) * 1980-05-21 1981-12-16 Otsuka Pharmaceut Co Ltd Preparation of antigen
US4423034A (en) * 1980-10-16 1983-12-27 Toyo Jozo Kabushiki Kaisha Process for the preparation of antibodies
US5693741A (en) 1988-03-15 1997-12-02 The Boeing Company Liquid molding compounds
US4430326A (en) 1981-12-22 1984-02-07 University Patents, Inc. Method of diminishing glucose levels resulting from endogenous glucagon
GB2160312B (en) * 1984-04-13 1987-09-16 South African Inventions Adjuvant for immunisation
FR2602679B1 (fr) * 1986-08-14 1989-02-24 Inst Nat Sante Rech Med Nouvelles compositions pharmaceutiques renfermant comme principe actif regulateur du mouvement des ions calcium un fragment du glucagon, et preparation d'un tel fragment
US5089390A (en) * 1987-09-04 1992-02-18 Syntex (U.S.A.) Inc. 2-methyl-4-hexene- and 2-methyl-4-heptene-1,2-diol derivatives
CA2363712C (en) * 1999-05-17 2011-05-10 Conjuchem Inc. Long lasting insulinotropic peptides
US7601691B2 (en) * 1999-05-17 2009-10-13 Conjuchem Biotechnologies Inc. Anti-obesity agents
US6887470B1 (en) 1999-09-10 2005-05-03 Conjuchem, Inc. Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
US20040266673A1 (en) * 2002-07-31 2004-12-30 Peter Bakis Long lasting natriuretic peptide derivatives
US20060223767A1 (en) * 2003-01-10 2006-10-05 Haruo Hanawa Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene therapy
DK2100904T3 (da) 2004-04-23 2010-11-08 Conjuchem Biotechnologies Inc Fast fase til anvendelse i en fremgangsmåde til rensning af albuminkonjugater
US8039432B2 (en) * 2005-11-09 2011-10-18 Conjuchem, Llc Method of treatment of diabetes and/or obesity with reduced nausea side effect
EP1976876A4 (en) * 2005-12-22 2010-01-13 Conjuchem Biotechnologies Inc PROCESS FOR PRODUCING PREFORMED ALBUMIN CONJUGATES AND THERAPEUTIC AGENT
US20090099074A1 (en) * 2007-01-10 2009-04-16 Conjuchem Biotechnologies Inc. Modulating food intake
KR20170062466A (ko) 2014-09-16 2017-06-07 리제너론 파마슈티칼스 인코포레이티드 항-글루카곤 항체 및 그것의 사용
MA46089A (fr) 2016-08-30 2019-07-10 Regeneron Pharma Procédés de traitement de la résistance à l'insuline grave par interférence avec la signalisation du récepteur du glucagon
US20190248888A1 (en) 2016-10-20 2019-08-15 Regeneron Pharmaceuticals, Inc. Methods of lowering blood glucose levels
CA3071387A1 (en) 2017-08-22 2019-02-28 Regeneron Pharmaceuticals, Inc. Methods of treating urea cycle disorders by interfering with glucagon receptor signaling

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1584386A (https=) * 1967-08-19 1969-12-19
DE1643345C3 (de) * 1967-08-19 1975-09-25 Hoechst Ag, 6000 Frankfurt Glucagonderivat und Verfahren zur Herstellung von Glucagon
US3979506A (en) * 1974-10-11 1976-09-07 Pierce Chemical Company Radioactive compounds for labeling proteins

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Clinica Chimica Acta, 22, 1968, S. 511-520
Nature, 4827, May 5, 1962, S. 495-496
NICHTS ERMITTELT *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009147A3 (en) * 1978-08-30 1980-04-30 Takeda Chemical Industries, Ltd. A method for enzyme immunoassay of pancreatic glucagon and a peptide-enzyme conjugate usable for the method
DE3039122A1 (de) * 1979-10-16 1981-04-30 Toyo Jozo K.K., Tagata, Shizuoka Glucagonfragment und seine verwendung

Also Published As

Publication number Publication date
US4206199A (en) 1980-06-03
FR2398051A1 (fr) 1979-02-16
DE2858718C2 (https=) 1989-07-06
DE2832090C2 (https=) 1989-07-20
FR2398051B1 (https=) 1983-09-16
GB2002387B (en) 1982-02-10
GB2002387A (en) 1979-02-21

Similar Documents

Publication Publication Date Title
DE2832090A1 (de) Glucagon-fragment und seine derivate
DE2509783C2 (de) Decapeptidamide und Verfahren zu deren Herstellung
DE3428942C2 (de) (h-pth)-peptidderivate
DE2321174C2 (de) Nonapeptidamid und Verfahren zu ihrer Herstellung
DE3211263C2 (https=)
DE68922602T2 (de) Polypeptide mit hormonwachstumsbefreiender wirkung.
DE2616399C2 (de) Desamino-1,7-dicarbacalcitonine und Verfahren zu ihrer Herstellung
DE2435027C2 (de) Nonapeptidamide und Verfahren zu ihrer Herstellung
DE3144818A1 (de) C-terminales fragment von menschlichem choriongonadotropin
DE3782010T2 (de) Vom calcitonin-gen abgeleitete peptidderivate.
DE69225597T2 (de) Peptide mit einer lanthionin-brücke
DE69915160T2 (de) Verfahren zur Herstellung des Somatostatin Analogons Octreotide
DE3120312A1 (de) Verfahren zur herstellung von darm-glucagon-antigen
DE2826844A1 (de) Neues, mit radioaktivem jod markiertes hentriacontapeptid, verfahren zu seiner herstellung und dessen verwendung
DE2315271C3 (de) L- Norleucin-13-Motilin, Verfahren zu dessen Herstellung und dasselbe enthaltendes Mittel
DE3039122A1 (de) Glucagonfragment und seine verwendung
DE2659758A1 (de) Carba-derivate von somatostatin, verfahren zu ihrer herstellung und arzneimittel
EP0051205B1 (de) Neues Tridekapeptid, Verfahren zu seiner Herstellung und Verwendung
DE3439610A1 (de) Immunogene, verfahren zu deren herstellung sowie damit gewonnene antikoerper gegen glykosiliertes haemoglobin
DE2112553C3 (de) 1 -alpha-Aminolsobuttersäurecorticotropinpeptide, deren Derivate, Säureadditionssalze und Komplexe sowie Arzneipräparate
DE2364883C2 (de) Des-Lys↑2↑↑9↑-Ala↑3↑↑0↑-Schweine- und -Rinderinsulin, Verfahren zu deren Herstellung und diese Insuline enthaltende injizierbare Präparate
DE3151738A1 (de) Peptid fuer die analyse des menschlichen hormons der nebenschilddruese
DE2450357A1 (de) Peptidverbindungen und verfahren zu deren herstellung
DE69014042T2 (de) Verfahren zur Herstellung von menschlichem Osteocalcin.
DE69229356T2 (de) NEUE VERBESSERUNGEN hinsichtlich der RADIOMARKIERUNG von PROTEINEn

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 2858718

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 2858718

AH Division in

Ref country code: DE

Ref document number: 2858718

Format of ref document f/p: P

AH Division in

Ref country code: DE

Ref document number: 2858718

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee